Ad Industry Survey: Advertisers Prioritizing Generative AI and CTV in 2025
In the survey conducted online by Start.io and AdTechGod™, roughly 90% of respondents said generative AI is impacting their work as advertisers. Most ad companies are still in their early stages with the technology, with roughly 38% of respondents saying they were piloting or testing generative AI applications.
Some 23% of respondents said generative AI has 'significantly transformed' their operations, while 28% said the technology had resulted in 'minor enhancements' to their work.
CTV remains the top channel for marketing spend in 2025, with 1 out of 3 respondents saying their clients planned to increase their spend on CTV. Mobile advertising and retail media followed closely behind, at 24% and 20%, respectively.
Mobile, first-party data signals remain the most trusted source of audience segmentation information, with 1 out of 3 respondents saying they trusted in-app data more than any other data source. Mobile ads are best for targeting, with nearly 57% of respondents saying they achieved the most accurate audience targeting on mobile devices.
Download the full report
About Start.io
Start.io is a sell-side omnichannel advertising platform powered by real-time mobile audiences. We deliver hundreds of millions of ads per day across thousands of active mobile apps and web publishers. Our platform uses artificial intelligence to deliver more efficient, effective, and precise digital advertising campaigns. Our direct integration with thousands of mobile publishers gives us access to more than 50 billion first-party data signals per day across the globe. Marketers use these anonymized signals to understand and predict consumer behavior, identify new opportunities, and fuel business growth.
Contact InformationMaya Carmely Director of Marketing
SOURCE: Start.io
press release
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
15 hours ago
- Associated Press
4 Steps to Budget When Living on Your Own in Lafayette, LA
NEW YORK CITY, NY / ACCESS Newswire / July 26, 2025 / Living on your own in Lafayette, LA, is a big step - and an exciting one. You get to make your own choices, create your own space and enjoy your independence. But living on your own also means being in charge of your own money, which may be overwhelming at first. Don't worry, you're not alone. Many people in Lafayette are learning how to manage their budgets and take control of their finances for the first time, just like you. And while it may seem challenging some days, the good news is that you could build smart money habits one step at a time. Whether you're paying rent, buying groceries or handling surprise costs, tools like budgeting, saving or looking into loans in Lafayette, LA, could help you stay on track. Keep reading for a few ways to care for your finances while living on your own. 1. Know what's coming in and going out The first step to creating a budget is understanding your income and expenses. Income is how much money you earn each month and expenses are how much you spend. Start by writing down your monthly income. If you get a regular paycheck, list how much money you earn after taxes. If you work different hours each week or have more than one job, try to estimate an average income based on what you've earned in the past few months. Next, write down your regular monthly expenses. These might include: Also, think about any bills that come up less often, like car insurance, which you may pay every six months or annually. Break those less frequent payments into monthly amounts so you don't forget to plan for them. Once you compare the money coming in and going out, you could see if you're spending more than you make or if you have funds left over to save. 2. Choose a budgeting method Choosing a budgeting method that fits your lifestyle may make managing money much easier. Consider the following well-known strategies: 3. Prepare for the unexpected Even if you have a solid plan, life doesn't always go the way you expect. Your car might break down, your pet might need to see a vet or you could lose hours at work. To deal with any unforeseen expenses, it's smart to set up an emergency fund. An emergency fund is money you set aside specifically for unexpected costs. Start small - even saving $20 a week can add up over time. If you don't have enough money saved and something urgent comes up, you might consider a personal loan to help cover car repairs, medical bills or other important expenses. A personal loan is a lump sum of money you borrow from a bank, credit union or other lender. You pay back the loan in fixed monthly installments over a pre-determined amount of time along with interest, which is the cost of borrowing money. Make sure you understand the terms of a loan before you borrow. Look at the interest rate, monthly payment amounts and the time it will take to repay. 4. Make saving a regular habit Saving money doesn't have to be hard. If you treat savings like a regular bill, it might become part of your routine. One simple method is setting up automatic transfers from your checking account to a savings account. Automatic transfers ensure that part of your paycheck gets saved without you even thinking about it. You could also make saving into a game. Set a goal to save $5 every time you skip a coffee or pack lunch instead of going out. Over time, you'll see how small choices could lead to big savings. Build your independence with smart money habits Living on your own comes with new responsibilities, but it also brings freedom and the opportunity to make your own financial choices. When you learn how to budget, save and prepare for the unexpected, you're giving yourself the tools to stay in control of your money - and your future. SPONSORED CONTENT CONTACT: Sonakshi Murze Manager [email protected] SOURCE: OneMain Financial press release
Hamilton Spectator
2 days ago
- Hamilton Spectator
PharmAla Issues Q3 Financial Statements
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. ('PharmAla' or the 'Company') (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for the period ended May 31, 2025. All figures are reported in Canadian dollars. The Company's full set of unaudited condensed interim consolidated financial statements for the quarter and accompanying management's discussion and analysis can be accessed by visiting the Company's website at and its profile page on SEDAR+ at . 'The re-opening of PharmAla's domestic Canadian distribution has allowed us to execute as much volume in Q2 and Q3 as we did in all of the last fiscal year. The creation of our Prescriber's Portal has also allowed us to build a much closer relationship with our doctor customers, which we believe will serve us well moving forward,' said Nick Kadysh, CEO, PharmAla Biotech. 'As we move into the last quarter of Fiscal '24-25, we are incredibly pleased that a large shipment of LaNeo MDMA has arrived at our US distribution partner for delivery to a considerable group of clinical trial customers, most previously announced. PharmAla is also pleased to announce the completion of a manufacturing run in Australia for our 40mg LaNeo Capsules. These capsules were jointly manufactured for both Cortexa's use within Australia and PharmAla's use worldwide, and our improved manufacturing process should yield operational benefits well into the future.' Financial Highlights: 'Over the past quarter, our team has made exciting progress to ensure a reliable supply of pharmaceutical product for both researchers in clinical trials and patients in need of treatment,' said Will Avery, CFO, PharmAla Biotech. 'Our Prescriber Platform continues to empower physicians to access the MDMA and provide treatment for their patients and we look forward to additional clinical trial fulfillment to US and international customers in the near term, unburdened by cross-border trade issues.' About PharmAla PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) is a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, including MDMA. PharmAla was founded with a dual focus: alleviating the global backlog of generic, clinical-grade MDMA to enable clinical trials as well as commercial sales in selected jurisdictions, and to develop novel drugs in the same class. PharmAla is the only company currently provisioning clinical-grade MDMA for patient treatments outside of clinical trials. PharmAla's research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. PharmAla is a 'regulatory first' organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators. For more information, please contact: Nicholas Kadysh Chief Executive Officer PharmAla Biotech Holdings Inc. Email: press@ Phone: 1-855-444-6362 Website: Neither the CSE nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as 'plans', 'strategy', 'expects' or 'does not expect', 'intends', 'continues', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or may contain statements that certain actions, events or results 'will be taken', 'will launch' or 'will be launching', 'will include', 'will allow', 'will be made' 'will continue', 'will occur' or 'will be achieved'. We direct readers to refer to the 'Caution Regarding Forward-Looking Statements' contained within the Company's management's discussion and analysis for the period ended May 31, 2025, as filed on Sedar+ . Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed in the Company's management's discussion and analysis, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at , which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.
Business Wire
2 days ago
- Business Wire
Sandisk Forms HBF™ Technical Advisory Board to Guide Development and Strategy for High-Bandwidth Flash Memory Technology
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) today announced the formation of a Technical Advisory Board to guide the development and strategy of its groundbreaking High Bandwidth Flash (HBF™) memory technology. The board includes industry experts and senior technical leaders from both within and outside the company. Appointed today, Professor David Patterson and Raja Koduri will provide strategic guidance, technical insight, market perspective, and shape open standards as Sandisk prepares to launch HBF. 'We're honored to have two distinguished computer architecture experts join our Technical Advisory Board,' said Alper Ilkbahar, Executive Vice President, Chief Technology Officer, and HBF Technical Advisory Board member at Sandisk. 'Their collective experience and strategic counsel will be instrumental in shaping HBF as the future memory standard for the AI industry, and affirming we not only meet but exceed the expectations of our customers and partners.' Professor David Patterson, Pardee Professor of Computer Science, Emeritus at the University of California at Berkeley and a Google distinguished engineer, will lead the Technical Advisory Board and guide the group toward actionable insights and decisions. He is a prominent computer scientist known for co-developing Reduced Instruction Set Computing (RISC), which revolutionized processor design. He played key roles in the development of Redundant Array of Inexpensive Disks (RAID), and Networks of Workstations (NOW). Patterson co-authored the seminal textbook Computer Architecture: A Quantitative Approach and was also awarded the 2017 ACM Turing Award for his contributions to the industry. 'HBF shows the promise of playing an important role in datacenter AI by delivering unprecedented memory capacity at high bandwidth, enabling inference workloads to scale far beyond today's constraints,' said Professor Patterson. 'It could drive down costs of new AI applications that are currently unaffordable.' Raja Koduri is a computer engineer and business executive renowned for leading graphics architecture, with previous positions at AMD as Senior Vice President and Chief Architect and at Intel as Executive Vice President of Accelerated Computing Systems and Graphics. He directed the development of AMD's Polaris, Vega, and Navi GPU architectures, Intel's Arc and Ponte Vecchio GPUs, and spearheaded Intel's foray into discrete graphics. In early 2023, he founded a startup focused on generative AI for gaming, media, and entertainment, and joined the Board of Tenstorrent in the AI and RISC‑V semiconductor space. Most recently, he serves as Founder/CEO of Oxmiq Labs and Co-Founder of Mihira Visual Studios and continues to shape graphics and AI innovation through advisory and board roles across the semiconductor industry. 'HBF is set to revolutionize edge AI by equipping devices with memory capacity and bandwidth capabilities that will support sophisticated models running locally in real time,' said Koduri. 'This advancement will unlock a new era of intelligent edge applications, fundamentally changing how and where AI inference is performed.' Introduced at Future FWD: Sandisk 2025 Investor Day, HBF is a breakthrough memory solution designed to augment High Bandwidth Memory (HBM) for AI inference workloads, offering comparable bandwidth while delivering up to 8x the capacity at a similar cost. Enabled by BiCS technology and CBA wafer bonding, HBF leverages proprietary stacking with ultra-low die warpage for 16-high configurations. Its architecture has been developed over the past year with input from leading AI industry players. For more information about HBF, please visit this Fact Sheet. About Sandisk Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, and YouTube. Join TeamSandisk on Instagram. Sandisk and the Sandisk logo are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the U.S. and/or other countries. All other marks are the property of their respective owners. Product specifications subject to change without notice. © 2025 Sandisk Corporation or its affiliates. All rights reserved.
